Halozyme Initiates Clinical Trial Of PEGPH20 With Anti-PDL1 Immunotherapy In Cholangiocarcinoma And Gallbladder …Markets InsiderSAN DIEGO, Oct. 16, 2017 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced initiation of a clinic… Continue reading
|
Creative Medical Technology Holdings Expands Stem Cell Therapeutic Platform by Entry into Field of Stroke and …
Markets Insider PHOENIX, Oct. 16, 2017 /PRNewswire/ — Creative Medical Technology Holdings (OTCQB: CELZ) announced today filing of a patent application using a combination of an FDA approved drug together with the patient’s own bone marrow derived stem cells for … LifeCell challenges ICMR’s recommendation to suspend commercial banking of stem cells from cord tissuepharmabiz.com Indian Council of Medical Research (ICMR) Bans Banking of Stem Cells from Biological MaterialsNYOOOZ (blog) |
Investor’s Business Daily |
Kite Pharma Cancer Treatment Stands Out In Hot CAR–T Field
Nasdaq Kite Pharma is edging closer to approval for a cutting-edge cancer treatment that fights the disease by rebuilding a patient’s own cells – a technology that could benefit thousands of people and pave the way for blockbuster drugs. [ibd-display-video … 6 Top Biotech Companies In Innovation Earn Recognition In New AwardsInvestor’s Business Daily IBD Announces First Annual Biotech Innovator AwardsMarkets Insider |
Retraction Watch (blog) |
Caught Our Notice: Investigation finds “accidental mistakes” in PNAS stem cell paper
Retraction Watch (blog) When Retraction Watch began in 2010, our co-founders Ivan Oransky and Adam Marcus quickly realized they couldn’t keep up with the hundreds of retractions that appeared each year. And the problem has only gotten worse — although we’ve added staff, … |
Investor’s Business Daily |
Technology
Investor’s Business Daily The approach, called CAR–T therapy, uses bioengineering to retrain a patient’s infection-fighting white blood cells to seek out and destroy cancer cells. Analysts say Kite’s manufacturing process stands out in the CAR–T field for its shorter turnaround … IBD Announces First Annual Biotech Innovator AwardsMarkets Insider |